Diabetes mellitus type 2 through oncology lens

Medical Hypotheses

Volumn 76, Issue 5, 2011, Pages 761-762

  Alfarouk, Khalid Omer ^a   Bashir, Adil H H ^b  

^a Africa City of Technology Khartoum   (Sudan)

^b Khartoum College for Medical Sciences   (Sudan)

Author keywords

[No Author keywords available]

Indexed keywords

CYANOCOBALAMIN; INSULIN; METFORMIN; TESTOSTERONE;

ANTINEOPLASTIC ACTIVITY; CARCINOGENESIS; DIABETIC PATIENT; HUMAN; INSULIN RESISTANCE; ISCHEMIA; LETTER; MALE INFERTILITY; NON INSULIN DEPENDENT DIABETES MELLITUS; ONCOLOGY; PERIPHERAL NEUROPATHY; TESTOSTERONE BLOOD LEVEL;

DIABETES COMPLICATIONS; DIABETES MELLITUS, TYPE 2; DISEASE PROGRESSION; FEMALE; HUMANS; INSULIN; ISCHEMIA; MALE; METFORMIN; MODELS, BIOLOGICAL; MODELS, THEORETICAL; POLYCYSTIC OVARY SYNDROME; PROSTATIC NEOPLASMS; VITAMIN B 12;

EID: 79954422454     PISSN: 03069877     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mehy.2011.01.031     Document Type: Letter

References (33)

1. Li D., Yeung S.C., Hassan M.M., Konopleva M., Abbruzzese J.L. Antidiabetic therapies affect risk of pancreatic cancer. Gastroenterology 2009, 137(2):482-488.
2. Odze R.D., Maley C.C. Neoplasia without dysplasia: lessons from Barrett esophagus and other tubal gut neoplasms. Arch Pathol Lab Med 2010, 134(6):896-906.
3. Evans J.M., Donnelly L.A., Emslie-Smith A.M., Alessi D.R., Morris A.D. Metformin and reduced risk of cancer in diabetic patients. BMJ 2005, 330(7503):1304-1305.
4. Gonzalez-Angulo A.M., Meric-Bernstam F. Metformin: a therapeutic opportunity in breast cancer. Clin Cancer Res 2010, 16(6):1695-1700.
5. Jalving M., Gietema J.A., Lefrandt J.D., de Jong S., Reyners A.K., Gans R.O., et al. Metformin: taking away the candy for cancer?. Eur J Cancer 2010, 46(13):2369-2380.
6. Hadad S.M., Fleming S., Thompson A.M. Targeting AMPK: a new therapeutic opportunity in breast cancer. Crit Rev Oncol Hematol 2008, 67(1):1-7.
7. Katsiki N., Georgiadou E., Hatzitolios A.I. The role of insulin-sensitizing agents in the treatment of polycystic ovary syndrome. Drugs 2009, 69(11):1417-1431.
8. Palomba S., Pasquali R., Orio F., Nestler J.E. Clomiphene citrate, metformin or both as first-step approach in treating anovulatory infertility in patients with polycystic ovary syndrome (PCOS): a systematic review of head-to-head randomized controlled studies and meta-analysis. Clin Endocrinol (Oxf) 2009, 70(2):311-321.
9. Palomba S., Falbo A., Orio F., Zullo F. Effect of preconceptional metformin on abortion risk in polycystic ovary syndrome: a systematic review and meta-analysis of randomized controlled trials. Fertil Steril 2009, 92(5):1646-1658.
10. Tang T., Lord J.M., Norman R.J., Yasmin E., Balen A.H. Insulin-sensitising drugs (metformin, rosiglitazone, pioglitazone, D-chiro-inositol) for women with polycystic ovary syndrome, oligo amenorrhoea and subfertility. Cochrane Database Syst Rev 2010, (1):CD003053.
11. Ozata M., Oktenli C., Bingol N., Ozdemir I.C. The effects of metformin and diet on plasma testosterone and leptin levels in obese men. Obes Res 2001, 9(11):662-667.
12. Oláh K.S. The modern management of hirsutism. Rev Gynaecol Pract 2004, (4):211-220.
13. Muthusamy T., Dhevika S., Murugesan P., Balasubramanian K. Testosterone deficiency impairs glucose oxidation through defective insulin and its receptor gene expression in target tissues of adult male rats. Life Sci 2007, 81(7):534-542.
14. Muthusamy T., Murugesan P., Balasubramanian K. Sex steroids deficiency impairs glucose transporter-4 expression and its translocation through defective Akt phosphorylation in target tissues of adult male rat. Metabolism 2009, 58(11):1581-1592.
15. El-Sakka A.I., Sayed H.M., Tayeb K.A. Androgen pattern in patients with type 2 diabetes-associated erectile dysfunction: impact of metabolic control. Urology 2009, 74(3):552-559.
16. Isoyama R., Kawai S., Shimizu Y., Harada H., Takihara H., Baba Y., et al. Clinical experience with methylcobalamin (CH3-B12) for male infertility. Hinyokika Kiyo 1984, 30(4):581-586.
17. Pront R., Margalioth E.J., Green R., Eldar-Geva T., Maimoni Z., Zimran A., et al. Prevalence of low serum cobalamin in infertile couples. Andrologia 2009, 41(1):46-50.
18. Bauman W.A., Shaw S., Jayatilleke E., Spungen A.M., Herbert V. Increased intake of calcium reverses vitamin b12 malabsorption induced by metformin. Diabetes Care 2000, 23:1227-1231.
19. Bell D.S. Metformin-induced vitamin B12 deficiency presenting as a peripheral neuropathy. South Med J 2010, 103(3):265-267.
20. Goto G.H., Katayama H., Tanigaki Y., Fushiki S., Nishizawa Y., Nishizawa Y. Methylcobalamin inhibits fibroblast growth factor-8 stimulated proliferation and induces apoptosis in Shionogi carcinoma cells. Int J Vitam Nutr Res 2008, 78(1):21-26.
21. Nishizawa Y., Yamamoto T., Terada N., Fushiki S., Matsumoto K., Nishizawa Y. Effects of methylcobalamin on the proliferation of androgen-sensitive or estrogen-sensitive malignant cells in culture and in vivo. Int J Vitam Nutr Res 1997, 67(3):164-170.
22. Collin S.M., et al. Circulating folate, vitamin B12, homocysteine, vitamin B12 transport proteins, and risk of prostate cancer: a case-control study, systematic review and meta-analysis. Cancer Epidemiol Biomarkers Prev 2010, 19(6):1632-1642.
23. Gatenby R.A., Gillies R.J. Why do cancers have high aerobic glycolysis?. Nat Rev Cancer 2004, 4(11):891-899.
24. Higuchi M. Regulation of mitochondrial DNA content and cancer. Mitochondrion 2007, 7(1-2):53-57.
25. Weiss G. Relaxin in the male. Biol Reprod 1989, 40(2):197-200.
26. Bani D. Relaxin as a natural agent for vascular health. Vasc Health Risk Manag 2008, 4(3):515-524.
27. Feng S., Agoulnik I.U., Bogatcheva N.V., Kamat A.A., Kwabi-Addo B., Li R., et al. Relaxin promotes prostate cancer progression. Clin Cancer Res 2007, 13(6):1695-1702.
28. Kamat A.A., Feng S., Agoulnik I.U., Kheradmand F., Bogatcheva N.V., Coffey D., et al. The role of relaxin in endometrial cancer. Cancer Biol Ther 2006, 5(1):71-77.
29. Gatenby R.A., Gillies R.J. A microenviromental model of Carcinogenesis. Nat Rev Cancer 2008, 8(1):56-61.
30. Martin N.K., Gaffney E.A., Gatenby R.A., Maini P.K. Tumour-stromal interactions in acid-mediated invasion: a mathematical model. J Theor Biol 2010, 267(3):461-470.
31. Goss P.E., Chambers A.F. Does tumor dormancy offer therapeutic target?. Nat Rev Cancer 2010, 10(12):871-877.
32. Fais S. Cannibalism: a way to feed on metastatic tumors. Cancer Lett 2007, 258(2):155-164.
33. Lozupone F., et al. The human homologue of dictyostelium discoideum phg1A is expressed by human metastatic melanoma cells. EMBO Rep 2009, 10(12):1348-1354.